Computex is always a great show to see the latest and best graphics cards from major manufacturers like MSI, Palit, Gigabyte, ...

Imagine drawing on something as delicate as a living cell -- without damaging it. Researchers have made this groundbreaking discovery using an unexpected combination of tools: frozen ethanol, electron ...

If you’ve been grinding through the Hellfire Gala Moments event in Marvel Rivals and suddenly hit a wall with Hellfire Gala Act 3 not working, you’re not alone.

SO AS YOU GET OUT INTO YOUR EVENING HOURS, THERE COULD BE SOME OF THESE WORKING IN FROM THE WEST AND STROLLING OVER PARTS OF THE METRO AREA OVER THE NEXT FEW HOURS THIS EVENING, COOL WITH ...

National Rugby League respects and honours the Traditional Custodians of the land and pay our respects to their Elders past, present and future. We acknowledge the stories, traditions and living ...

Since AI workloads are best handled by graphics cards, NVIDIA was poised to meet the moment better than any other company on the market. Not only were its GPUs known to be among the best on offer ...

This cutting-edge field represents the convergence of artificial intelligence, sensor technology, and biotechnology. For investors looking beyond the quarterly hype cycle, this emerging sector ...

Shenzhen Genocury Biotech Co., Ltd. is a clinical-stage biotechnology pioneer redefining in vivo cell engineering through its proprietary Vivoexpress™ platform. This modular delivery system ...

Oversupply and demand dampened by a pullback in venture capital have plagued biotech landlords for more than a year, causing steep increases in vacancy in even the top life sciences markets.

In the basement of 55 Church St. sits one of just three NeuroExplorer PET scanners in the world. Capable of producing images with significantly better resolution and sensitivity than its 20-year-old ...

Top business executives and industry experts convened Tuesday at the 2025 US Strategy Roundtable for Pharma and Biotech to assess Korea’s biotech standing at a critical juncture of global ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.